These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29562982)

  • 21. CD4+ cell count stratification to guide tuberculosis preventive therapy for people living with HIV.
    Chaisson LH; Saraceni V; Cohn S; Seabrook D; Cavalcante SC; Chaisson RE; Golub JE; Durovni B
    AIDS; 2020 Jan; 34(1):139-147. PubMed ID: 31634189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of the human immunodeficiency virus on early multidrug-resistant tuberculosis treatment outcomes in Botswana.
    Hafkin J; Modongo C; Newcomb C; Lowenthal E; MacGregor RR; Steenhoff AP; Friedman H; Bisson GP
    Int J Tuberc Lung Dis; 2013 Mar; 17(3):348-53. PubMed ID: 23321297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil.
    Golub JE; Saraceni V; Cavalcante SC; Pacheco AG; Moulton LH; King BS; Efron A; Moore RD; Chaisson RE; Durovni B
    AIDS; 2007 Jul; 21(11):1441-8. PubMed ID: 17589190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of isoniazid preventive therapy on tuberculosis or death in persons with HIV: a retrospective cohort study.
    Ayele HT; van Mourik MS; Bonten MJ
    BMC Infect Dis; 2015 Aug; 15():334. PubMed ID: 26269094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) study.
    Durovni B; Cavalcante SC; Saraceni V; Vellozo V; Israel G; King BS; Cohn S; Efron A; Pacheco AG; Moulton LH; Chaisson RE; Golub JE
    AIDS; 2010 Nov; 24 Suppl 5(Suppl 5):S49-56. PubMed ID: 21079428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isoniazid Prophylactic Therapy for the Prevention of Tuberculosis in HIV Infected Adults: A Systematic Review and Meta-Analysis of Randomized Trials.
    Ayele HT; Mourik MS; Debray TP; Bonten MJ
    PLoS One; 2015; 10(11):e0142290. PubMed ID: 26551023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and predictors of tuberculosis among HIV patients who completed isoniazid preventive therapy (IPT) at Reach out Mbuya community health initiative.
    Sekayi W; Namyalo E; Namayanja J; Kungu JM
    Sci Rep; 2023 Oct; 13(1):17602. PubMed ID: 37845357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implementation of isoniazid preventive therapy in an HIV clinic in Cambodia: high rates of discontinuation when combined with antiretroviral therapy.
    van Griensven J; Choun K; Chim B; Thai S; Lorent N; Lynen L
    Trop Med Int Health; 2015 Dec; 20(12):1823-31. PubMed ID: 26426387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Barriers to and motivations for the implementation of a treatment programme for latent tuberculosis infection using isoniazid for people living with HIV, in upper northern Thailand.
    Moolphate S; Lawpoolsri S; Pungrassami P; Sanguanwongse N; Yamada N; Kaewkungwal J
    Glob J Health Sci; 2013 Mar; 5(4):60-70. PubMed ID: 23777722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Derivation and external validation of a risk score for predicting HIV-associated tuberculosis to support case finding and preventive therapy scale-up: A cohort study.
    Auld AF; Kerkhoff AD; Hanifa Y; Wood R; Charalambous S; Liu Y; Agizew T; Mathoma A; Boyd R; Date A; Shiraishi RW; Bicego G; Mathebula-Modongo U; Alexander H; Serumola C; Rankgoane-Pono G; Pono P; Finlay A; Shepherd JC; Ellerbrock TV; Grant AD; Fielding K
    PLoS Med; 2021 Sep; 18(9):e1003739. PubMed ID: 34491987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of isoniazid preventive therapy among people living with HIV in Kenya: A retrospective study of routine health care data.
    Karanja M; Kingwara L; Owiti P; Kirui E; Ngari F; Kiplimo R; Maina M; Masini E; Onyango E; Ngugi C
    PLoS One; 2020; 15(12):e0234588. PubMed ID: 33264300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tuberculin skin testing to assess the occupational risk of Mycobacterium tuberculosis infection among health care workers in Abidjan, Côte d'Ivoire.
    Kassim S; Zuber P; Wiktor SZ; Diomande FV; Coulibaly IM; Coulibaly D; Kadio A; Yapi A; Touré KC; Blekou PB; Irié B; Greenberg AE; Binkin NJ
    Int J Tuberc Lung Dis; 2000 Apr; 4(4):321-6. PubMed ID: 10777080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-treatment effect of isoniazid preventive therapy on tuberculosis incidence in HIV-infected individuals on antiretroviral therapy.
    Sumner T; Houben RM; Rangaka MX; Maartens G; Boulle A; Wilkinson RJ; White RG
    AIDS; 2016 May; 30(8):1279-86. PubMed ID: 26950316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isoniazid tuberculosis preventive therapy in HIV-infected adults accessing antiretroviral therapy: a Botswana Experience, 2004-2006.
    Mosimaneotsile B; Mathoma A; Chengeta B; Nyirenda S; Agizew TB; Tedla Z; Motsamai OI; Kilmarx PH; Wells CD; Samandari T
    J Acquir Immune Defic Syndr; 2010 May; 54(1):71-7. PubMed ID: 19934764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective cohort study of outcomes for isoniazid prevention therapy: a nested study from a national QI collaborative in Uganda.
    Sensalire S; Karungi Karamagi Nkolo E; Nabwire J; Lawino A; Kiragga D; Muhire M; Kadama H; Katureebe C; Namuwenge P; Musinguzi J; Calnan J; Seyoum D
    AIDS Res Ther; 2020 May; 17(1):28. PubMed ID: 32460788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Depression and delayed tuberculosis treatment initiation among newly diagnosed patients in Botswana.
    Molebatsi K; Wang Q; Dima M; Ho-Foster A; Modongo C; Zetola N; Shin SS
    Glob Public Health; 2021 Jul; 16(7):1088-1098. PubMed ID: 32991275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The timing of tuberculosis after isoniazid preventive therapy among gold miners in South Africa: a prospective cohort study.
    Hermans SM; Grant AD; Chihota V; Lewis JJ; Vynnycky E; Churchyard GJ; Fielding KL
    BMC Med; 2016 Mar; 14():45. PubMed ID: 27004413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Agents of change: The role of healthcare workers in the prevention of nosocomial and occupational tuberculosis.
    Nathavitharana RR; Bond P; Dramowski A; Kotze K; Lederer P; Oxley I; Peters JA; Rossouw C; van der Westhuizen HM; Willems B; Ting TX; von Delft A; von Delft D; Duarte R; Nardell E; Zumla A
    Presse Med; 2017 Mar; 46(2 Pt 2):e53-e62. PubMed ID: 28256382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants for tuberculosis in HIV-infected adults in Northwest Ethiopia: a multicentre case-control study.
    Alemu YM; Awoke W; Wilder-Smith A
    BMJ Open; 2016 Apr; 6(4):e009058. PubMed ID: 27084271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of isoniazid preventive therapy completion among HIV-infected patients receiving differentiated and non-differentiated HIV care in rural Uganda.
    Tram KH; Mwangwa F; Chamie G; Atukunda M; Owaraganise A; Ayieko J; Jain V; Clark TD; Kwarisiima D; Petersen ML; Kamya MR; Charlebois ED; Havlir DV; Marquez C;
    AIDS Care; 2020 Jan; 32(1):119-127. PubMed ID: 31181961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.